Patient dosing has begun in a phase 1 trial evaluating QXL138AM, a masked immunocytokine targeting CD138, in advanced solid ...
Three area nonprofits are among the organizations that will receive $550,000 in grants from the Rhode Island Foundation. The ...
But when an EV’s battery does become compromised — as occurred during the Tesla incident in Toronto — every reduced risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback